The magnetic resonance imaging (mri) guided and focused ultrasound devices market size has grown rapidly in recent years. It will grow from $3.14 billion in 2025 to $3.51 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growth in minimally invasive procedures, advancement in mri imaging resolution, rising prevalence of oncology disorders, increased adoption of image-guided therapies, clinical validation of focused ultrasound.
The magnetic resonance imaging (mri) guided and focused ultrasound devices market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of non-invasive neurosurgical treatments, integration of ai-based therapy control, growing demand for outpatient treatment solutions, rising investments in precision medicine, broader regulatory approvals for focused ultrasound. Major trends in the forecast period include MRI-guided non-invasive therapy, ai-assisted treatment planning, real-time image-guided precision ablation, integrated imaging and therapy platforms, data-driven treatment monitoring.
The growing incidence of neurological disorders is expected to drive the expansion of the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in the coming years. Neurological disorders, which impact the brain, spinal cord, and nerves, result in a variety of symptoms such as cognitive, motor, and sensory impairments. The increasing prevalence of these disorders is largely due to the aging global population, as the natural aging process weakens neuronal function, reduces brain plasticity, and increases oxidative stress, all of which contribute to the onset and progression of neurological conditions. MRI-guided focused ultrasound devices support the diagnosis of neurological disorders by providing real-time imaging alongside non-invasive treatment capabilities, making them effective for precisely targeting affected areas of the brain. These devices improve diagnostic accuracy and treatment planning by offering high-resolution visualization and focused therapy, ultimately leading to better patient outcomes and clinical efficiency. For instance, the National Health Service (NHS) reported in July 2024 that 487,432 patients had been diagnosed with dementia, a progressive condition that affects memory, thinking, and daily activities, marking an increase of 3,155 cases since May 2024. Thus, the rising prevalence of neurological disorders is driving the growth of the MRI-guided focused ultrasound devices market.
Leading companies in the MRI-guided focused ultrasound devices market are focusing on developing advanced products, such as next-generation MR-guided focused ultrasound systems, to enhance precision, broaden clinical applications, and improve patient outcomes. These systems combine real-time MRI imaging with high-intensity focused ultrasound, offering better precision, automation, usability, and expanded clinical capabilities compared to earlier models. For example, in January 2024, Insightec Ltd., an Israel-based medical technology company, introduced the Exablate Prime system, an advanced MR-guided focused ultrasound (MRgFUS) platform. The system integrates intelligently designed algorithms, automated workflows, and seamless connectivity with hospital systems such as PACS, enabling remote planning and technical support from physicians. Its enhanced computing architecture allows for up to 150 reports, and it includes a high-resolution monitor for optimized imaging, along with a cross transducer designed for optimal performance during MR-guided procedures. Built on a decade of research and user feedback, the Exablate Prime system aims to provide unparalleled precision in neurosurgical treatments, including those for essential tremor and Parkinson’s disease, while reducing procedure times and improving operational efficiency.
In February 2025, Grovecourt Capital Partners LLC, a US-based investment firm, acquired IMRIS Imaging Inc. for an undisclosed amount. Through this acquisition, Grovecourt Capital Partners aims to expand its portfolio in medical imaging and advanced surgical technologies, strengthening its position in high-growth healthcare markets. The acquisition also grants Grovecourt access to IMRIS’s expertise in MRI-guided and hybrid operating room solutions. IMRIS Imaging Inc. is a US-based manufacturer specializing in MRI-guided focused ultrasound devices.
Major companies operating in the magnetic resonance imaging (mri) guided and focused ultrasound devices market are InSightec Ltd, EDAP TMS SA, Image Guided Therapy SA, Profound Medical Inc, Cardiawave, Focal One, FUS Instruments Inc, Theraclion SA, Siemens Healthineers, GE Healthcare, Koninklijke Philips NV, EpiSonica Corp, Kona Medical Inc, Mirabilis Medical Inc, Chongqing Haifu Technology Co Ltd, Shanghai A&S Co Ltd, Shenzhen PRO‑HIFU Medical Tech Co Ltd, Changjiangyuan Technology Development Co Ltd, Wuxi Haiying Medical Co Ltd, Elekta AB, CarThera, Monteris Medical, Eye Tech Care, HistoSonics Inc, NaviFUS Corp, NeuroBlate (Monteris Medical)†, HIFU Devices Inc.
North America was the largest region in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the magnetic resonance imaging (mri) guided and focused ultrasound devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the magnetic resonance imaging (mri) guided and focused ultrasound devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the magnetic resonance imaging (MRI) guided and focused ultrasound devices market by increasing prices of imported imaging components, ultrasound transducers, and precision electronics. These impacts are most evident in advanced system segments and in regions such as North America and Europe that depend on Asia-Pacific manufacturing hubs. Elevated system costs can slow hospital procurement and technology upgrades. However, tariffs are encouraging localized manufacturing, supplier diversification, and innovation in modular and cost-efficient MRI-guided focused ultrasound platforms.
The magnetic resonance imaging (mri) guided and focused ultrasound devices market research report is one of a series of new reports that provides magnetic resonance imaging (mri) guided and focused ultrasound devices market statistics, including magnetic resonance imaging (mri) guided and focused ultrasound devices industry global market size, regional shares, competitors with a magnetic resonance imaging (mri) guided and focused ultrasound devices market share, detailed magnetic resonance imaging (mri) guided and focused ultrasound devices market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (mri) guided and focused ultrasound devices industry. This magnetic resonance imaging (mri) guided and focused ultrasound devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Magnetic resonance imaging (MRI)-guided focused ultrasound devices are advanced medical technologies that combine MRI imaging with high-intensity focused ultrasound to precisely target specific tissues. These devices provide non-invasive treatment by delivering focused energy while continuously monitoring the treatment area with MRI for accuracy and safety. They help minimize damage to surrounding healthy tissues and reduce the need for surgical intervention.
The primary types of MRI-guided focused ultrasound devices are MRI-guided systems and focused ultrasound systems. MRI-guided systems use MRI technology to visualize and monitor internal tissues and organs in real time, allowing clinicians to guide, plan, and assess procedures with high precision and without ionizing radiation. Based on treatment types, these devices are classified as thermal ablation, non-thermal ablation, and drug delivery systems, utilizing technologies such as MRI-guided ultrasound, focused ultrasound therapy, ultrasound imaging systems, and combination systems. Applications span oncology, neurology, cardiology, urology, and others, serving end users including hospitals, clinics, ambulatory surgical centers, and research and academic institutes.
The magnetic resonance imaging (MRI)-guided focused ultrasound devices market consists of revenues earned by entities by providing services such as image-guided therapy procedures, non-invasive treatment planning, system maintenance, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The magnetic resonance imaging (MRI)-guided focused ultrasound devices market also includes sales of transducers, treatment planning software, patient positioning systems, and related accessories and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The magnetic resonance imaging (mri) guided and focused ultrasound devices market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of non-invasive neurosurgical treatments, integration of ai-based therapy control, growing demand for outpatient treatment solutions, rising investments in precision medicine, broader regulatory approvals for focused ultrasound. Major trends in the forecast period include MRI-guided non-invasive therapy, ai-assisted treatment planning, real-time image-guided precision ablation, integrated imaging and therapy platforms, data-driven treatment monitoring.
The growing incidence of neurological disorders is expected to drive the expansion of the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in the coming years. Neurological disorders, which impact the brain, spinal cord, and nerves, result in a variety of symptoms such as cognitive, motor, and sensory impairments. The increasing prevalence of these disorders is largely due to the aging global population, as the natural aging process weakens neuronal function, reduces brain plasticity, and increases oxidative stress, all of which contribute to the onset and progression of neurological conditions. MRI-guided focused ultrasound devices support the diagnosis of neurological disorders by providing real-time imaging alongside non-invasive treatment capabilities, making them effective for precisely targeting affected areas of the brain. These devices improve diagnostic accuracy and treatment planning by offering high-resolution visualization and focused therapy, ultimately leading to better patient outcomes and clinical efficiency. For instance, the National Health Service (NHS) reported in July 2024 that 487,432 patients had been diagnosed with dementia, a progressive condition that affects memory, thinking, and daily activities, marking an increase of 3,155 cases since May 2024. Thus, the rising prevalence of neurological disorders is driving the growth of the MRI-guided focused ultrasound devices market.
Leading companies in the MRI-guided focused ultrasound devices market are focusing on developing advanced products, such as next-generation MR-guided focused ultrasound systems, to enhance precision, broaden clinical applications, and improve patient outcomes. These systems combine real-time MRI imaging with high-intensity focused ultrasound, offering better precision, automation, usability, and expanded clinical capabilities compared to earlier models. For example, in January 2024, Insightec Ltd., an Israel-based medical technology company, introduced the Exablate Prime system, an advanced MR-guided focused ultrasound (MRgFUS) platform. The system integrates intelligently designed algorithms, automated workflows, and seamless connectivity with hospital systems such as PACS, enabling remote planning and technical support from physicians. Its enhanced computing architecture allows for up to 150 reports, and it includes a high-resolution monitor for optimized imaging, along with a cross transducer designed for optimal performance during MR-guided procedures. Built on a decade of research and user feedback, the Exablate Prime system aims to provide unparalleled precision in neurosurgical treatments, including those for essential tremor and Parkinson’s disease, while reducing procedure times and improving operational efficiency.
In February 2025, Grovecourt Capital Partners LLC, a US-based investment firm, acquired IMRIS Imaging Inc. for an undisclosed amount. Through this acquisition, Grovecourt Capital Partners aims to expand its portfolio in medical imaging and advanced surgical technologies, strengthening its position in high-growth healthcare markets. The acquisition also grants Grovecourt access to IMRIS’s expertise in MRI-guided and hybrid operating room solutions. IMRIS Imaging Inc. is a US-based manufacturer specializing in MRI-guided focused ultrasound devices.
Major companies operating in the magnetic resonance imaging (mri) guided and focused ultrasound devices market are InSightec Ltd, EDAP TMS SA, Image Guided Therapy SA, Profound Medical Inc, Cardiawave, Focal One, FUS Instruments Inc, Theraclion SA, Siemens Healthineers, GE Healthcare, Koninklijke Philips NV, EpiSonica Corp, Kona Medical Inc, Mirabilis Medical Inc, Chongqing Haifu Technology Co Ltd, Shanghai A&S Co Ltd, Shenzhen PRO‑HIFU Medical Tech Co Ltd, Changjiangyuan Technology Development Co Ltd, Wuxi Haiying Medical Co Ltd, Elekta AB, CarThera, Monteris Medical, Eye Tech Care, HistoSonics Inc, NaviFUS Corp, NeuroBlate (Monteris Medical)†, HIFU Devices Inc.
North America was the largest region in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the magnetic resonance imaging (mri) guided and focused ultrasound devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the magnetic resonance imaging (mri) guided and focused ultrasound devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the magnetic resonance imaging (MRI) guided and focused ultrasound devices market by increasing prices of imported imaging components, ultrasound transducers, and precision electronics. These impacts are most evident in advanced system segments and in regions such as North America and Europe that depend on Asia-Pacific manufacturing hubs. Elevated system costs can slow hospital procurement and technology upgrades. However, tariffs are encouraging localized manufacturing, supplier diversification, and innovation in modular and cost-efficient MRI-guided focused ultrasound platforms.
The magnetic resonance imaging (mri) guided and focused ultrasound devices market research report is one of a series of new reports that provides magnetic resonance imaging (mri) guided and focused ultrasound devices market statistics, including magnetic resonance imaging (mri) guided and focused ultrasound devices industry global market size, regional shares, competitors with a magnetic resonance imaging (mri) guided and focused ultrasound devices market share, detailed magnetic resonance imaging (mri) guided and focused ultrasound devices market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (mri) guided and focused ultrasound devices industry. This magnetic resonance imaging (mri) guided and focused ultrasound devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Magnetic resonance imaging (MRI)-guided focused ultrasound devices are advanced medical technologies that combine MRI imaging with high-intensity focused ultrasound to precisely target specific tissues. These devices provide non-invasive treatment by delivering focused energy while continuously monitoring the treatment area with MRI for accuracy and safety. They help minimize damage to surrounding healthy tissues and reduce the need for surgical intervention.
The primary types of MRI-guided focused ultrasound devices are MRI-guided systems and focused ultrasound systems. MRI-guided systems use MRI technology to visualize and monitor internal tissues and organs in real time, allowing clinicians to guide, plan, and assess procedures with high precision and without ionizing radiation. Based on treatment types, these devices are classified as thermal ablation, non-thermal ablation, and drug delivery systems, utilizing technologies such as MRI-guided ultrasound, focused ultrasound therapy, ultrasound imaging systems, and combination systems. Applications span oncology, neurology, cardiology, urology, and others, serving end users including hospitals, clinics, ambulatory surgical centers, and research and academic institutes.
The magnetic resonance imaging (MRI)-guided focused ultrasound devices market consists of revenues earned by entities by providing services such as image-guided therapy procedures, non-invasive treatment planning, system maintenance, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The magnetic resonance imaging (MRI)-guided focused ultrasound devices market also includes sales of transducers, treatment planning software, patient positioning systems, and related accessories and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Characteristics
3. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Supply Chain Analysis
4. Global Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Trends and Strategies
5. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Analysis of End Use Industries
7. Global Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Total Addressable Market (TAM) Analysis for the Market
9. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Segmentation
10. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Regional and Country Analysis
11. Asia-Pacific Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
12. China Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
13. India Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
14. Japan Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
15. Australia Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
16. Indonesia Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
17. South Korea Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
18. Taiwan Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
19. South East Asia Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
20. Western Europe Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
21. UK Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
22. Germany Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
23. France Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
24. Italy Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
25. Spain Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
26. Eastern Europe Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
27. Russia Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
28. North America Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
29. USA Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
30. Canada Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
31. South America Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
32. Brazil Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
33. Middle East Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
34. Africa Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market
36. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Competitive Landscape and Company Profiles
37. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market Other Major and Innovative Companies
40. Magnetic Resonance Imaging (Mri) Guided and Focused Ultrasound Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses magnetic resonance imaging (mri) guided and focused ultrasound devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for magnetic resonance imaging (mri) guided and focused ultrasound devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The magnetic resonance imaging (mri) guided and focused ultrasound devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Magnetic Resonance Imaging (MRI) Guided; Focused Ultrasound2) By Treatment Type: Thermal Ablation; Non-Thermal Ablation; Drug Delivery Systems
3) By Technology: Magnetic Resonance Imaging (MRI) Guided Ultrasound; Focused Ultrasound Therapy; Combination Systems
4) By Application: Oncology; Neurology; Cardiology; Urology; Other Applications
5) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Research And Academic Institutes
Subsegments:
1) By Magnetic Resonance Imaging (MRI) Guided: High-Intensity Focused Ultrasound (HIFU); Low-Intensity Focused Ultrasound (LIFU)2) By Focused Ultrasound: Therapeutic Focused Ultrasound; Diagnostic Focused Ultrasound; Neurological Applications; Urological Applications; Oncological Applications
Companies Mentioned: InSightec Ltd; EDAP TMS SA; Image Guided Therapy SA; Profound Medical Inc; Cardiawave; Focal One; FUS Instruments Inc; Theraclion SA; Siemens Healthineers; GE Healthcare; Koninklijke Philips NV; EpiSonica Corp; Kona Medical Inc; Mirabilis Medical Inc; Chongqing Haifu Technology Co Ltd; Shanghai A&S Co Ltd; Shenzhen PRO‑HIFU Medical Tech Co Ltd; Changjiangyuan Technology Development Co Ltd; Wuxi Haiying Medical Co Ltd; Elekta AB; CarThera; Monteris Medical; Eye Tech Care; HistoSonics Inc; NaviFUS Corp; NeuroBlate (Monteris Medical)†; HIFU Devices Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices market report include:- InSightec Ltd
- EDAP TMS SA
- Image Guided Therapy SA
- Profound Medical Inc
- Cardiawave
- Focal One
- FUS Instruments Inc
- Theraclion SA
- Siemens Healthineers
- GE Healthcare
- Koninklijke Philips NV
- EpiSonica Corp
- Kona Medical Inc
- Mirabilis Medical Inc
- Chongqing Haifu Technology Co Ltd
- Shanghai A&S Co Ltd
- Shenzhen PRO‑HIFU Medical Tech Co Ltd
- Changjiangyuan Technology Development Co Ltd
- Wuxi Haiying Medical Co Ltd
- Elekta AB
- CarThera
- Monteris Medical
- Eye Tech Care
- HistoSonics Inc
- NaviFUS Corp
- NeuroBlate (Monteris Medical)†
- HIFU Devices Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.51 Billion |
| Forecasted Market Value ( USD | $ 5.43 Billion |
| Compound Annual Growth Rate | 11.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
